Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | 0.0114 | 0.6817 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0142 | 1 | 1 |
Echinococcus granulosus | furin | 0.0142 | 1 | 1 |
Loa Loa (eye worm) | endoprotease bli-4 | 0.0142 | 1 | 1 |
Brugia malayi | celfurPC protein | 0.0114 | 0.6817 | 0.4795 |
Schistosoma mansoni | subfamily S8B unassigned peptidase (S08 family) | 0.0142 | 1 | 1 |
Echinococcus multilocularis | neuroendocrine convertase 2 | 0.0089 | 0.3886 | 0.1038 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0086 | 0.3546 | 0.5 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0086 | 0.3546 | 0.5 |
Echinococcus granulosus | neuroendocrine convertase 2 | 0.0089 | 0.3886 | 0.0526 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC (functional) | = 3.12 ug ml-1 | Antibacterial activity against Escherichia coli ATCC 25922 after 18 to 25 hrs by serial plate dilution method | ChEMBL. | 21907466 |
MIC (functional) | = 3.12 ug ml-1 | Antibacterial activity against Escherichia coli ATCC 25922 after 18 to 24 hrs by serial plate dilution method | ChEMBL. | 21920636 |
MIC (functional) | = 25 ug ml-1 | Antimycobacterial activity against isoniazid, rifampicin and ethambuto-resistant Mycobacterium tuberculosis using compound level ranging from 0.3125 to 5 ug/mL after 7 days by resazurin reduction test | ChEMBL. | 21907466 |
MIC (functional) | = 25 ug ml-1 | Antimycobacterial activity against isoniazid, rifampicin and ethambutol-resistant Mycobacterium tuberculosis at 0.3125 to 5 ug/mL after 7 days by Resazurin assay | ChEMBL. | 21920636 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.